Treating Multiple Sclerosis with a Breakthrough Drug

Critical Conversation

Please join us for a conversation with Dennis Bourdette, MD, FANA, FAAN and Laura Wieden as they discuss the development of a breakthrough drug for multiple sclerosis.

09 Sep

This conversation was livestreamed on September 9.

Help support the OHSU Department of Neurology and the innovative research in the fight against multiple sclerosis. MAKE A GIFT TODAY.

For more information about supporting OHSU’s groundbreaking work in multiple sclerosis, please contact:
Maddy Abulencia, Director of Development
[email protected]

For years, OHSU has been on the front lines in attacking MS. Now, thanks to innovative “high-risk” research funded by philanthropy, a breakthrough drug that could stimulate critical myelin repair will start clinical trials within a year, raising expectations of MS patients worldwide. Hear the powerful story of the doctor who wouldn’t give up, and a grateful patient who has new hope thanks to research her family has generously supported.

Presenters:

Laura Wieden, OHSU Patient and Philanthropist

Dennis Bourdette, MD, FANA, FAAN, Professor Emeritus of Neurology, OHSU School of Medicine